Clinical trials: Self-sampling
Coronavirus
Self-sampling for the Study of COVID-19
This study will evaluate the feasibility of self-sampling with the iAMP® COVID-19 Detection Kit (Atila BioSystems, Mountain View, CA), a new, low-cost SARS-CoV-2 test that does not require RNA extraction.
- Trial name
- NCT04447495
- Testing
- iAMP test
- Where
- United States
- Volunteers
- 126 people
- Sponsor
- Medical College of Wisconsin
Cervical Cancer
Self-sampling for Non-participants in an Organised Cervical Cancer Screening Programme
The trial will evaluate the effect on participation in organised screening programme of a human papilloma virus (HPV) self-sampling kit directly mailed home or mailed on demand compared with the standard second reminder for…
- Trial name
- CHOiCE (NCT02680262)
- Testing
- HPV self-sampling kit mailed directly, HPV self-sampling kit on demand, Second reminder
- Where
- Denmark
- Volunteers
- 9,327 people
- Sponsor
- University of Aarhus
HIV Infection, Syphilis
Strengthening, Guidance, Health, Empowerment
The goal of this interventional study is to describe the care pathway following the use of an innovative home self-sampling method for the screening of six sexually transmitted infections (STIs) among sex workers met during…
- Conditions
- HIV Infection, Syphilis, Gonorrhea Infection, Chlamydia Infection
- Trial name
- ROSE (NCT07788599)
- Testing
- Self-sampling for six sexually transmitted infections
- Where
- France
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- University Hospital, Montpellier
Respiratory Failure
RASECAL-Bronchoscopic Ambusampler
Prospective, multi-centre, open labelled, 1:1randomized controlled study.
- Trial name
- Rasecal (NCT05964075)
- Where
- United Kingdom
- Volunteers
- 207 people
- Sponsor
- Chelsea and Westminster NHS Foundation Trust
HPV
Self-Sampling for Human Papillomavirus (HPV) at Well Women Appointments
This study seeks to compare the accuracy and acceptability of Human Papillomavirus (HPV) testing self-sampling kit versus standard clinician-sampled HPV testing for cervical cancer screening.
- Trial name
- NCT04591977
- Testing
- HPV Self-Sampling Kit (Evalyn Brush)
- Where
- United States
- Volunteers
- 46 people
- Sponsor
- Milton S. Hershey Medical Center
Cervical Cancer, Cervical Cancer Screening
Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment.
- Conditions
- Cervical Cancer, Cervical Cancer Screening, HPV DNA
- Trial name
- DADA-LINK (NCT07050745)
- Testing
- DADA LINK
- Where
- Kenya
- Volunteers
- 1,980 people, healthy volunteers welcome
- Sponsor
- Kenyatta National Hospital
Healthy Adult Participants, Gynecological Disease
Methylation Analyses for Gynaecological Research Through Home-based Self-sampling
The goal of the MARGOT study is to collect self-samples, such as first-void urine and vaginal samples, from people without cancer and compare them with samples from people with gynecological (pre-)cancers collected in other…
- Trial name
- MARGOT (NCT07902388)
- Testing
- Colli-Pee 20 mL device with UCM, Evalyn Brush
- Where
- Belgium
- Volunteers
- 512 people, healthy volunteers welcome
- Sponsor
- Universiteit Antwerpen
Anxiety Depression, Emotion Regulation
Improving Emotion Regulation Flexibility: Testing the Efficacy of an Emotion Regulation Program in College Students
The main objective of this RCT is to test the efficacy of an emotion regulation group program (i.e., ART program) in college students, compared to an active control group (i.e., relaxation program).
- Trial name
- REFLEX (NCT05390034)
- Testing
- ART, Relaxation
- Where
- France
- Volunteers
- 94 people, healthy volunteers welcome
- Sponsor
- University Hospital, Grenoble
Cervical Cancer, Cervical Intraepithelial Neoplasia
CASUS: Validation for Detection of Precursor Lesions
The goal of the overall CASUS project is to develop the first fully molecular integrated cervical cancer screening approach, based on first-void urine as an easily accessible and non-invasive source of biomarkers.
- Conditions
- Cervical Cancer, Cervical Intraepithelial Neoplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
- Trial name
- CASUS-WP4 (NCT04530201)
- Testing
- Colli-Pee Small Volumes (10 mL) device
- Where
- 3 sites in Belgium
- Volunteers
- 332 people
- Sponsor
- Universiteit Antwerpen
Uterine Cervical Neoplasms, Uterine Cervical Dysplasia
Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention
Scientific Context High-risk types of human papillomavirus (HPV) are the causative agents for cervical cancer. Cervical cancer screening strategies rely on periodic Papanicolaou (Pap) testing.
- Trial name
- APACHE-1 (NCT01014026)
- Testing
- Screening test
- Where
- 5 sites in France
- Volunteers
- 734 people
- Sponsor
- University Hospital, Tours
Cervical Cancer
SElf-SAMpling in Cervical Cancer Screening; SESAM Study
Study aims to support development of evidence based health care in Norway through evaluating recently proposed technological improvements in cervical cancer control before their routine use.
- Trial name
- SESAM (NCT02945891)
- Testing
- HPV testing of Evalyn®Brush, FloqSwab and Colli-Pee specimens
- Where
- 4 sites in Norway
- Volunteers
- 310 people
- Sponsor
- Oslo University Hospital
Periodontitis, Diagnostic Self Evaluation
Diagnostic Accuracy of Matrix Metalloproteinase-8 Test for the Discrimination of Periodontal Health and Disease
The application of point-of-care test with oral fluid-based biomarkers assisting in early-detection of gum disease is highly needed.
- Trial name
- NCT05099731
- Where
- China
- Volunteers
- 95 people, healthy volunteers welcome
- Sponsor
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Diabetes Mellitus
Self Monitoring of Blood Glucose With Finger Tip vs. Alternate Site Sampling: Effect on Long Term Glycemic Control
The objective is to assess the effect of using ASBG (alternate site blood glucose) versus FTBG (finger tip blood glucose) testing on long-term glycemic control in diabetics.
- Trial name
- NCT00207207
- Testing
- Alternate site blood glucose testing
- Where
- United States
- Volunteers
- 174 people
- Sponsor
- Boston Medical Center
Human Papilloma Virus Infection
Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
The aim of the study is to develop robust analytical protocols for first-void urine sample preparation and antibody assays to monitor natural and/or vaccine induced immunity against HPV (Human Papillomavirus).
- Trial name
- AB-SOP (NCT02714114)
- Testing
- First-void urine collection, Blood draw
- Where
- Belgium
- Volunteers
- 57 people, healthy volunteers welcome
- Sponsor
- Universiteit Antwerpen
HPV, HPV Associated Cancers
Emergency Department-based Cervical Cancer Screening Through Self-sampling
This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.
- Conditions
- HPV, HPV Associated Cancers, HPV Cancers, Cervical Cancer Screening
- Trial name
- NCT07345897
- Testing
- Cervical Cancer Screening
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- University of Rochester
Diabetes Mellitus
Comparison of First and Second Capillary Blood Drops for Blood Glucose Measurement
This study aimed to evaluate the effects of different capillary blood sampling techniques on blood glucose measurement results in people with diabetes.
- Trial name
- NCT07624266
- Testing
- Capillary Blood Sampling Techniques
- Where
- Turkey (Türkiye)
- Volunteers
- 64 people
- Sponsor
- Ordu University
Cervical Intraepithelial Neoplasia Grade 2/3, Carcinoma Cervix
Extended VALidation of HUman Papillomavirus Assays and Collection DEvices for HPV Testing on Self-samples
The "Extended VALHUDES" study is a Clinical Performance / Diagnostic Test Accuracy Study that aims to extend validation, achieved as part of the "Belgian VALHUDES", of HPV testing using BD Onclarity on samples collected using…
- Trial name
- Ext-VALHUDES (NCT04788849)
- Testing
- BD Onclarity™ HPV assay
- Where
- 2 sites in Italy
- Volunteers
- 300 people
- Sponsor
- University of Milano Bicocca
Human Papilloma Virus Infection
Developing Methods to Investigate Additional Opportunities of HPV Vaccination by Using First-void Urine Samples
The main objective of this study is to develop protocols using FV urine that investigate in vitro whether infectious virions can be neutralized by HPV vaccination.
- Trial name
- HPV-VACPLUS (NCT04391647)
- Testing
- First-void urine collection, Blood draw
- Where
- Belgium
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Universiteit Antwerpen
Cervical Cancer, Cervical Intraepithelial Neoplasia
CASUS: Improved and Quality Assured Collection of First-void Urine
The goal of the overall CASUS project is to develop the first fully molecular integrated cervical cancer screening approach, based on first-void urine as an easily accessible and non-invasive source of biomarkers.
- Conditions
- Cervical Cancer, Cervical Intraepithelial Neoplasia, Human Papilloma Virus, HPV-Related Cervical Carcinoma
- Trial name
- CASUS-WP1 (NCT04480866)
- Testing
- Colli-Pee® (FV5000 and Small Volumes)
- Where
- Belgium
- Volunteers
- 25 people
- Sponsor
- Universiteit Antwerpen
Cervical Cancer, Human Papilloma Virus
SMS Messaging for Invitation in the Cervical Cancer Screening Programme
A study on two different methods of invitation to participate to the cervical cancer screening programme will be conducted within a demonstration project to switch from cytology-based screening to HPV-based screening using…
- Trial name
- CERCA-SMS (NCT05362669)
- Testing
- SMS invitation, Phone call invitation
- Where
- Spain
- Volunteers
- 450 people, healthy volunteers welcome
- Sponsor
- Institut Català d'Oncologia